NPPA caps trade margins for 137 non-scheduled anti-cancer drugs

Government caps trade margin for 137 cancer drugs at 30%, prices likely to fall by up to 70%

The decision was approved at NPPA meetings on October 16 and 17, according to the minutes, seen by HT.

Govt caps trade margins on 137 anti-cancer drugs at 30%; retail prices likely to fall 70%

New Delhi, Oct 17: Drug pricing regulator NPPA on Saturday capped trade margins on 137 non-scheduled anti-cancer formulations at 30 per cent, according to an official statement. The move, effective November 9, is expected to slash retail prices of these critical life-saving medicines by up to 70 per cent depending on their current price structures, the Ministry of Chemicals and Fertilisers statement said. The National Pharmaceutical Pricing Auth…

Government caps trade margins on 137 anti-cancer drugs at 30%

Revised prices shall come into effect from Nov 9, says gazette notification; manufacturers asked to submit revised MRP to pricing authority within 7 days

Cancer drug prices may fall up to 70% from November 9 — What to know

Under the new directive, pharmaceutical companies must publish revised price lists on their official websites and circulate them widely among retailers and hospitals.

Govt. caps trade margins on 137 anti-cancer drugs

NPPA caps trade margins on 137 anti-cancer drugs to cut MRPs up to 70% and improve affordability, effective Nov 9.

137 cancer drugs to see price cuts of up to 70% from November 9

Cancer drug prices in India could drop by up to 70% under a new NPPA order covering 137 anti-cancer drugs. The revised prices take effect on November 9, 2026, with trade margins capped at 30 per cent.